CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED PURSUANT TO ITEM 601(B)(10)(IV) OF REGULATION S-K UNDER THE SECURITIES ACT OF 1933, AS AMENDED, BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO...Research Collaboration and Option Agreement • August 4th, 2021 • Morphic Holding, Inc. • Pharmaceutical preparations
This Amendment No. 2 to Research Collaboration and Option Agreement (this “Second Amendment”) is dated as of June 18, 2021 (the “Amendment Effective Date”) by and between:
